Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism.

Journal: Cell

Published: 2020-03-05

DOI: 10.1016/j.cell.2020.02.035

Affiliations: 27

Authors: 41

Go to article
Institutions Share
Klinik für Neurologie, RUB, Germany 0.27
Institute of Biochemistry and Pathobiochemistry, RUB, Germany 0.06
Experimental and Clinical Research Center (ECRC), Germany 0.05
The Mina and Everard Goodman Faculty of Life Sciences, BIU, Israel 0.05
Clinical-Microbiomics A/S, Denmark 0.05
Department of Medicine 3 - Rheumatology and Immunology, FAU, Germany 0.05
Institute for Nanotechnology and Advanced Materials (BINA), BIU, Israel 0.05
Institute for Agricultural and Nutritional Sciences, MLU, Germany 0.05
Faculty of Medicine, UR, Germany 0.05
Institute of Neuropathology, Uni Freiburg, Germany 0.04
Biological and Medical Research Center (BMFZ), HHU, Germany 0.02
University Hospital Duesseldorf (UKD), Germany 0.02
Max Delbrück Center for Molecular Medicine (MDC), Germany 0.02
Faculty of Biology and Biotechnology, RUB, Germany 0.02
St. Josef-Hospital, RUB, Germany 0.02
Faculty of Medicine, RUB, Germany 0.02
Institute for Medical Informatics, Statistics and Epidemiology (IMISE), Leipzig University, Germany 0.02
Evangelisches Krankenhaus Hattingen, Germany 0.02
Berlin Institute for Medical Systems Biology (BIMSB), MDC, Germany 0.02
Faculty of Medicine, Uni Freiburg, Germany 0.02
Leibniz Institute for Analytical Sciences (ISAS), Germany 0.01
UCLA Department of Integrative Biology and Physiology (IBP), United States of America (USA) 0.01
UCLA Brain Research Institute (BRI), United States of America (USA) 0.01
Cluster of Excellence - Centre for Integrative Biological Signalling Studies (CIBSS), Uni Freiburg, Germany 0
Cluster of Excellence - Center for Biological Signalling Studies (BIOSS), Uni Freiburg, Germany 0
Center for Basics in NeuroModulation (NeuroModulBasics), Uni Freiburg, Germany 0

Return